1. Executive Summary 2. Introduction 2.1 Heart Valves: An Overview 2.2 Mitral Regurgitation: An Overview 2.2.1 Transcatheter Mitral Valve Timeline 2.2.2 Types of MR 2.2.3 MR Clinical Guidelines 2.3 Aortic Valve v/s Mitral Valve 3. Global Market Analysis 3.1 Global Mitral Regurgitation Market: An Analysis 3.1.1 Global MR Market by Number of Patients 3.1.2 Global MR Market by Patient Severity 3.2 Global Degenerative Mitral Regurgitation Market: An Analysis 3.2.1 Global DMR Market by Number of Patients and Prevalence of TMVR 3.3 Global Functional Mitral Regurgitation Market: An Analysis 3.3.1 Global FMR Market by Number of Patients and Prevalence of TMVR 3.4 Global TMVR Market: An Analysis 3.4.1 Global TMVR Market by Value 3.4.2 Global TMVR Market by Volume 4. Regional Market Analysis 4.1 US TMVR Market: An Analysis 4.1.1 US MR Market by Number of Patients and Patient Severity 4.1.2 US DMR Market by Number of Patients and Prevalence of TMVR 4.1.3 US FMR Market by Number of Patients and Prevalence of TMVR 4.1.4 US TMVR Market by Value and Volume 4.2 Europe TMVR Market: An Analysis 4.2.1 Europe MR Market by Number of Patients and Patient Severity 4.2.2 Europe DMR Market by Number of Patients and Prevalence of TMVR 4.2.3 Europe FMR Market by Number of Patients and Prevalence of TMVR 4.2.4 Europe TMVR Market by Value and Volume 5. Market Dynamics 5.1 Growth Drivers 5.1.1 Increase in Patients with Congenital Heart Disease and Rheumatic Fever 5.1.2 Low Success Rate of Repair in FMR Patients 5.1.3 Aging Population 5.1.4 Increase in Prevalence of Mitral Valve Disease 5.1.5 Mitral Stenosis 5.2 Challenges 5.2.1 Patient Not Referred for Surgery 5.2.2 Complexity 5.2.3 Successful Surgical Repair 5.2.4 Risks to Surrounding Structures 5.3 Market Trends 5.3.1 Repair v/s Replacement 5.3.2 Different Approaches 5.3.3 Types of Surgery 6. Competitive Landscape 6.1 Global TMVR Market by Players 6.2 Global TMVR Market by Key Players 6.3 Comparison of Key Players in The Global TMVR Market by Design 7. Company Profiling 7.1 Edward Lifecsiences Incorporation 7.1.1 Business Overview 7.1.2 Financial Overview 7.1.3 Business Strategy 7.2 Abbott Laboratories 7.2.1 Business Overview 7.2.2 Financial Overview 7.2.3 Business Strategy 7.3 Medtronic 7.3.1 Business Overview 7.3.2 Financial Overview 7.3.3 Business Strategy List of Figures Figure 1: Transcatheter Mitral Valve Timeline Figure 2: Transcatheter Mitral Valve Clinical Guidelines Figure 3: Global MR Market by Number of Patients; 2014-2021 (Million) Figure 4: Global MR Market by Patient Severity and Eligibility for Treatment; 2014-2021 Figure 5: Global DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021 Figure 6: Global DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021 Figure 7: Global FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021 Figure 8: Global FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021 Figure 9: Global TMVR Market by Value; 2017-2021 (US$ Million) Figure 10: Global TMVR Market by Volume; 2017-2021 (Units) Figure 11: US MR Market by Number of Patients; 2014-2021 (Million) Figure 12: US MR Market by Patient Severity; 2014-2021 Figure 13: US DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021 Figure 14: US DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021 Figure 15: US FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021 Figure 16: US FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021 Figure 17: US TMVR Market by Value; 2016-2021 (US$ Million) Figure 18: US TMVR Market by Volume; 2016-2021 (Units) Figure 19: Europe MR Market by Number of Patients; 2014-2021 (Million) Figure 20: Europe MR Market by Patient Severity; 2014-2021 (Million) Figure 21: Europe DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021 Figure 22: Europe High Risk DMR Market by Number of Patients and Prevalence of TMVR; 2014-2021 (‘000) Figure 23: Europe FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021 Figure 24: Europe High Risk FMR Market by Number of Patients and Prevalence of TMVR; 2014-2021 (‘000) Figure 25: Europe TMVR Market by Value; 2015-2021 (US$ Million) Figure 26: Europe TMVR Market by Volume; 2015-2021 (Units) Figure 27: Global FMR Patients; 2014-2020 (‘000) Figure 28: Global Population Above 65 Years; 2010-2015 (Million) Figure 29: Prevalence of Mitral Valve Disease in the US by Age Group Figure 30: Types of Surgery for MR Figure 31: Edward Lifesciences Net sales; 2011-2015 (US$ Billion) Figure 32: Edward Lifesciences Net sales by Segments; 2015 Figure 33: Abbott Laboratories Net Sales; 2011-2015 (US$ Billion) Figure 34:Abbott Laboratories Net Sales by Segments; 2015 Figure 35: Medtronic Net Sales; 2011-2015 (US$ Billion) Figure 36: Medtronic Net Sales by Segments; 2015 Table 1: Types of Mitral Regurgitation Table 2: MR Surgery Class and Level Table 3: Comparison of Aortic Valve and Mitral Valve Table 4: Repair v/s Replacement of Valve Table 5: Companies in the Global TMVR Market Table 6: Key Players in the Global TMVR Market: Overview Table 7: Design Comparison of the Devices of Key Players in the Global TMVR Market